{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:11:20Z","timestamp":1781104280753,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,10]]},"DOI":"10.7759\/cureus.110598","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:05:36Z","timestamp":1781100336000},"source":"Crossref","is-referenced-by-count":0,"title":["Ancillary Diagnostic Utility of Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) in Diagnostically Challenging Hepatic Angiomyolipoma"],"prefix":"10.7759","author":[{"given":"Suyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Zaki","family":"Karzoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paari","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robben","family":"Schat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Ankeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung U","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i19.2299","article-title":"Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: a literature review","volume":"27","author":"Calame P","year":"2021","unstructured":"Calame P, Tyrode G, Weil Verhoeven D, et al.. Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: a literature review. World J Gastroenterol. 2021, 27:2299-311. 10.3748\/wjg.v27.i19.2299","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaf056","article-title":"PEComa-its clinical features, histopathology, and current therapy","volume":"55","author":"Izubuchi Y","year":"2025","unstructured":"Izubuchi Y, Tanaka T. PEComa-its clinical features, histopathology, and current therapy. Jpn J Clin Oncol. 2025, 55:691-8. 10.1093\/jjco\/hyaf056","journal-title":"Jpn J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.rct.0000152863.97865.47","article-title":"Magnetic resonance imaging of adrenal angiomyolipoma","volume":"29","author":"Elsayes KM","year":"2005","unstructured":"Elsayes KM, Narra VR, Lewis JS, Jr., Brown JJ. Magnetic resonance imaging of adrenal angiomyolipoma. J Comput Assist Tomogr. 2005, 29:80-2. 10.1097\/01.rct.0000152863.97865.47","journal-title":"J Comput Assist Tomogr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2019.09.135","article-title":"Imaging hepatic angiomyolipomas: key features and avoiding errors","volume":"75","author":"Seow J","year":"2020","unstructured":"Seow J, McGill M, Wang W, Smith P, Goodwin M. Imaging hepatic angiomyolipomas: key features and avoiding errors. Clin Radiol. 2020, 75:88-99. 10.1016\/j.crad.2019.09.135","journal-title":"Clin Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105799","article-title":"Unlocking diagnostic potential: A retrospective analysis of GPNMB immunohistochemistry in nearly 1000 surgical pathology specimens","volume":"159","author":"Li H","year":"2025","unstructured":"Li H, Matoso A. Unlocking diagnostic potential: A retrospective analysis of GPNMB immunohistochemistry in nearly 1000 surgical pathology specimens. Hum Pathol. 2025, 159:105799. 10.1016\/j.humpath.2025.105799","journal-title":"Hum Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100426","article-title":"Glycoprotein nonmetastatic melanoma protein B (GPNMB) immunohistochemistry can be a useful ancillary tool to identify perivascular epithelioid cell tumor","volume":"37","author":"Wangsiricharoen S","year":"2024","unstructured":"Wangsiricharoen S, Ingram DR, Morey RR, Wani K, Lazar AJ, Wang WL. Glycoprotein nonmetastatic melanoma protein B (GPNMB) immunohistochemistry can be a useful ancillary tool to identify perivascular epithelioid cell tumor. Mod Pathol. 2024, 37:100426. 10.1016\/j.modpat.2024.100426","journal-title":"Mod Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ans.13880","article-title":"Clinico-pathological correlation of hepatic angiomyolipoma: a series of 23 resection cases","volume":"88","author":"Jung DH","year":"2018","unstructured":"Jung DH, Hwang S, Hong SM, et al.. Clinico-pathological correlation of hepatic angiomyolipoma: a series of 23 resection cases. ANZ J Surg. 2018, 88:60-5. 10.1111\/ans.13880","journal-title":"ANZ J Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST- 2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler JJ","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E, et al.. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST- 2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013, 381:817-24. 10.1016\/S0140-6736(12)61767-X","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/his.15005","article-title":"TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas","volume":"83","author":"Giannikou K","year":"2023","unstructured":"Giannikou K, Klonowska K, Tsuji J, et al.. TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas. Histopathology. 2023, 83:569-81. 10.1111\/his.15005","journal-title":"Histopathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.11.003","article-title":"Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations","volume":"61","author":"Jimbo N","year":"2017","unstructured":"Jimbo N, Nishigami T, Noguchi M, et al.. Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations. Hum Pathol. 2017, 61:41-8. 10.1016\/j.humpath.2016.11.003","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.08.008","article-title":"Angiomyolipoma of the kidney: from simple hamartoma to complex tumour","volume":"53","author":"Calio A","year":"2021","unstructured":"Calio A, Brunelli M, Segala D, et al.. Angiomyolipoma of the kidney: from simple hamartoma to complex tumour. Pathology. 2021, 53:129-40. 10.1016\/j.pathol.2020.08.008","journal-title":"Pathology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2012.04306.x","article-title":"Angiomyolipoma of the liver: a reappraisal of morphological features and delineation of new characteristic histological features from the clinicopathological findings of 55 tumours in 47 patients","volume":"61","author":"Nonomura A","year":"2012","unstructured":"Nonomura A, Enomoto Y, Takeda M, Takano M, Morita K, Kasai T. Angiomyolipoma of the liver: a reappraisal of morphological features and delineation of new characteristic histological features from the clinicopathological findings of 55 tumours in 47 patients. Histopathology. 2012, 61:863-80. 10.1111\/j.1365-2559.2012.04306.x","journal-title":"Histopathology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.72","article-title":"Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors","volume":"26","author":"He W","year":"2013","unstructured":"He W, Cheville JC, Sadow PM, et al.. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Mod Pathol. 2013, 26:1355-64. 10.1038\/modpathol.2013.72","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318206f2a9","article-title":"Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification","volume":"35","author":"Nese N","year":"2011","unstructured":"Nese N, Martignoni G, Fletcher CD, et al.. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011, 35:161-76. 10.1097\/PAS.0b013e318206f2a9","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181d90370","article-title":"Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy","volume":"34","author":"Brimo F","year":"2010","unstructured":"Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010, 34:715-22. 10.1097\/PAS.0b013e3181d90370","journal-title":"Am J Surg Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00891.x","article-title":"Malignant angiomyolipoma of the liver: a hitherto unreported variant","volume":"36","author":"Dalle I","year":"2000","unstructured":"Dalle I, Sciot R, de Vos R, et al.. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000, 36:443-50. 10.1046\/j.1365-2559.2000.00891.x","journal-title":"Histopathology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/his.13509","article-title":"Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis","volume":"73","author":"Yan Z","year":"2018","unstructured":"Yan Z, Grenert JP, Joseph NM, Ren C, Chen X, Shafizadeh N, Kakar S. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis. Histopathology. 2018, 73:101-8. 10.1111\/his.13509","journal-title":"Histopathology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/his.15405","article-title":"Risk prediction criteria for the primary hepatic perivascular epithelioid cell tumour family, including angiomyolipoma: analysis of 132 cases with a literature review","volume":"86","author":"Yoo Y","year":"2025","unstructured":"Yoo Y, Kim J, Song IH. Risk prediction criteria for the primary hepatic perivascular epithelioid cell tumour family, including angiomyolipoma: analysis of 132 cases with a literature review. Histopathology. 2025, 86:979-92. 10.1111\/his.15405","journal-title":"Histopathology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200101000-00007","article-title":"Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers","volume":"25","author":"Zavala-Pompa A","year":"2001","unstructured":"Zavala-Pompa A, Folpe AL, Jimenez RE, et al.. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers. Am J Surg Pathol. 2001, 25:65-70. 10.1097\/00000478-200101000-00007","journal-title":"Am J Surg Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000133","article-title":"Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases","volume":"38","author":"Schoolmeester JK","year":"2014","unstructured":"Schoolmeester JK, Howitt BE, Hirsch MS, Dal Cin P, Quade BJ, Nucci MR. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol. 2014, 38:176-88. 10.1097\/PAS.0000000000000133","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5858\/2002-126-0049-MMIAOT","article-title":"Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study","volume":"126","author":"Makhlouf HR","year":"2002","unstructured":"Makhlouf HR, Ishak KG, Shekar R, Sesterhenn IA, Young DY, Fanburg-Smith JC. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. Arch Pathol Lab Med. 2002, 126:49-55. 10.5858\/2002-126-0049-MMIAOT","journal-title":"Arch Pathol Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-122-DEOMMI","article-title":"Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas","volume":"131","author":"Roma AA","year":"2007","unstructured":"Roma AA, Magi-Galluzzi C, Zhou M. Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Arch Pathol Lab Med. 2007, 131:122-5. 10.5858\/2007-131-122-DEOMMI","journal-title":"Arch Pathol Lab Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.178","article-title":"Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis","volume":"27","author":"Miettinen M","year":"2014","unstructured":"Miettinen M. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis. Mod Pathol. 2014, 27:S17-29. 10.1038\/modpathol.2013.178","journal-title":"Mod Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13381","article-title":"Management of hepatic angiomyolipoma: a systematic review","volume":"37","author":"Klompenhouwer AJ","year":"2017","unstructured":"Klompenhouwer AJ, Verver D, Janki S, et al.. Management of hepatic angiomyolipoma: a systematic review. Liver Int. 2017, 37:1272-80. 10.1111\/liv.13381","journal-title":"Liver Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501212-ancillary-diagnostic-utility-of-glycoprotein-nonmetastatic-melanoma-protein-b-gpnmb-in-diagnostically-challenging-hepatic-angiomyolipoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:05:36Z","timestamp":1781100336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501212-ancillary-diagnostic-utility-of-glycoprotein-nonmetastatic-melanoma-protein-b-gpnmb-in-diagnostically-challenging-hepatic-angiomyolipoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.110598","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}